#CholesterolChat

Here can be your content

Promote Yourself on Twipu

Promote Yourself on Twipu

Quoted @pnatarajanmd

My pleasure! Learned a lot from you and @ErinMichos

#CholesterolGuidelines #CholesterolChat

0
1
4
The Heart Care Ayurvedic capsules Omega 3 has Anti-lipidemic, Cardioprotective, astringent & antioxidant properties.

#CholesterolChat  #Ayurvedic  #diet  #health  #healthcare  #Ayurveda  #HerbalifeNutrition  #AmazonPrime
2

The Heart Care Ayurvedic capsules Omega 3 has Anti-lipidemic, Cardioprotective, astringent & antioxidant properties. #CholesterolChat #Ayurvedic #diet #health #healthcare #Ayurveda #HerbalifeNutrition #AmazonPrime

Replying to @NHMAmd

A8: It’s important to understand social determinants that contribute to CV risk. When making treatment recommendations, consider challenges patients may face: neighborhood safety, healthy food availability, transportation, health insurance. #ACCMember @ErinMichos #CholesterolChat

0
0
5

Replying to @NHMAmd

A4: If clinical #ASCVD on maximally tolerated statin with LDL-C >70: reasonable to add #ezetimibe if at very high risk (COR IIa) or at high risk (COR IIb). #ACCMember @ErinMichos #CholesterolChat

0
0
2

Replying to @NHMAmd

A4: If <75 y/o with clinical #ASCVD, high-intensity #statin should be initiated or continued with aim of >50% LDL-C reduction (COR I). #ACCMember @ErinMichos #CholesterolChat

0
0
1

Replying to @NHMAmd

A4: Statin therapy is 1st line Rx for primary prevention of #ASCVD in patients w/ 1) elevated LDL-C ≥190 mg/dL, 2) diabetes mellitus aged 40-75, 3) those determined to be at sufficient ASCVD risk after a clinician-patient risk discussion. #ACCMember @ErinMichos #CholesterolChat

0
2
4

Thanks @AHAScience @ACCinTouch @NHMAmd for sharing this important info to improve #CVD health!! #CholesterolChat

1
1
3

Replying to @NHMAmd

A7: Among 1488 Hispanic participants in MESA followed over 10yrs, after adjustment for CVD risk factors, each doubling of #CAC associated w/ 14% increased #ASCVD risk in Hispanics [HR 1.14 (1.09-1.20)] https://www.ncbi.nlm.nih.gov/pubmed/29688297  #ACCMember @ErinMichos #CholesterolChat

1
2
8

Replying to @NHMAmd

A7: When #ASCVD risk uncertain, #CAC may be considered to refine risk estimation & guide clinician-patient risk discussion about statin Rx. In Hispanic participants in MESA, CAC score strongly associated w/ 10yr ASCVD risk in graded fashion #ACCMember @ErinMichos #CholesterolChat

1
3
8
Thanks for joining! We had a great time chatting #cholesterol with @NHMAmd &amp; @AHAScience. Check out our Cholesterol Guideline Hub for apps, tools &amp; more! http://fal.cn/sAq2  #CholesterolChat

Thanks for joining! We had a great time chatting #cholesterol with @NHMAmd & @AHAScience. Check out our Cholesterol Guideline Hub for apps, tools & more! http://fal.cn/sAq2  #CholesterolChat

Quoted @ErinMichos

A3: #FamilyHistory of dyslipidemia or early ASCVD is an important consideration. Children with a positive family history should undergo selective screening for dyslipidemia earlier than the recommended universal screening timeframe. #ACCMember @ErinMichos #CholesterolChat

A3. Full agree! Family history of #prematureCVD is so important. Children with high risk should be screened earlier!#cholesterolchat

0
4
9

Replying to @NHMAmd

A7: “Risk enhancing factors” favoring initiation of statin Rx in primary prevention include family history of premature ASCVD, metabolic syndrome, #CKD, #autoimmune disease, #preeclampsia, early #menopause, elevated #apoB, #LPa or #hsCRP. #ACCMember @ErinMichos #CholesterolChat

0
3
5
NHMA
a month ago

Time’s up! Thanks for participating in the #CholesterolChat with our AMAZING co-hosts @ACCinTouch & @AHAScience.

0
2
3
A8b: The Check. Change. Control. Cholesterol™ recognition program helps participants improve clinical practice while celebrating them for their hard work. Learn more:  http://spr.ly/6013EqpGV   #CholesterolChat

A8b: The Check. Change. Control. Cholesterol™ recognition program helps participants improve clinical practice while celebrating them for their hard work. Learn more: http://spr.ly/6013EqpGV  #CholesterolChat

Replying to @NHMAmd

A7: Primary prevention, adults 40-75y, guidelines recommend estimating 10yr #ASCVD risk by PCE. PCEs best validated in US non-Hispanic whites & blacks. May not work as well in Hispanics. Important to consider other “risk enhancing factors”. #ACCMember @ErinMichos #CholesterolChat

0
2
9

Replying to @NHMAmd

A7: Assess risk. When considering drug therapy for cholesterol management, estimation of #ASCVD risk facilitates matching intensity of therapy to one’s absolute risk to maximize anticipated benefits & minimize harms of over-treatment. #ACCMember @ErinMichos #CholesterolChat

0
2
5
A8a Our Check. Change. Control. Cholesterol™ Recognition Program acknowledges ambulatory health centers &amp; systems in their efforts to reduce heart attacks &amp; strokes by managing cholesterol in at-risk populations. http://spr.ly/6015Eqp1P  #Cholesterolchat

A8a Our Check. Change. Control. Cholesterol™ Recognition Program acknowledges ambulatory health centers & systems in their efforts to reduce heart attacks & strokes by managing cholesterol in at-risk populations. http://spr.ly/6015Eqp1P  #Cholesterolchat

NHMA
a month ago

A8. NHMA has a Cholesterol Management Campaign! Visit our website for more information: http://www.nhmamd.org/programs/nhma-cholesterol/ … #CholesterolChat

0
1
4
A8. Check out ACC’s @CardioSmart cholesterol condition center to help patients learn more about high cholesterol, treatment options &amp; the 2018 Cholesterol Guideline: http://fal.cn/sAt3  #CholesterolChat

A8. Check out ACC’s @CardioSmart cholesterol condition center to help patients learn more about high cholesterol, treatment options & the 2018 Cholesterol Guideline: http://fal.cn/sAt3  #CholesterolChat

NHMA
a month ago
LAST QUESTION! 
Q8. Is there a program my facility can join to help inspire people to manage their cholesterol? #CholesterolChat

LAST QUESTION! Q8. Is there a program my facility can join to help inspire people to manage their cholesterol? #CholesterolChat

Next Page